SEIKAGAKU CORPORATION

4548・Prime Market・Pharmaceuticals

Official website

SEIKAGAKU CORPORATION

4548・Prime Market・Pharmaceuticals

Official website

SEIKAGAKU CORPORATION4548

Reference Indicators

Market Cap

415¥100M

P/E (Forecast)

17.7x

P/B

0.5x

Dividend Yield (Forecast)

4.11%

ROE

2.0%

EV/EBITDA

21.7x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	34,851	33,456	36,213	39,374	36,645
Cost of Sales	14,323	15,432	19,336	20,221	20,673
Gross Profit	20,528	18,024	16,877	19,153	15,972
SG&A Expenses	16,033	15,910	16,444	17,819	16,632
Operating Income	4,495	2,114	433	1,333	-660
Non-operating Income	1,005	967	1,304	891	2,367
Non-operating Expenses	105	12	45	291	27
Ordinary Income	5,395	3,069	1,691	1,933	1,679
Extraordinary Losses	—	—	—	—	169
Pre-tax Income	5,395	3,069	1,691	1,933	1,510
Income Taxes	1,661	832	-495	718	36
Net Income	3,733	2,236	2,186	1,214	1,473
EBITDA	5,545	3,441	2,096	3,328	1,511
Gross Margin	58.9%	53.9%	46.6%	48.6%	43.6%
Operating Margin	12.9%	6.3%	1.2%	3.4%	-1.8%
ROA	5.0%	3.0%	2.7%	1.4%	1.7%
ROE	5.7%	3.3%	3.1%	1.7%	2.0%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品	24,493	-1,635	-6.7%
ＬＡＬ	12,152	975	8.0%